Concepedia

Yann Wallez

YW

Statistics

Publications

17

Citations

984

H-Index

16

Active since

2005

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

University of California San Diego

AstraZeneca (United Kingdom)

University of Cambridge

Inserm

Yann Wallez is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in life sciences, oncology, and cell signaling.

ORCID

Publications per year

2005–2022

17

Publications

17

Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site

Yann Wallez, Francine Cand, Francisco Cruzalegui et al. · Oncogene · 2006 · 229 citations

, , +13

Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues

Nathalie Lambeng, Yann Wallez, Christine Rampon et al. · Circulation Research · 2005 · 130 citations · Full text

, , +13

Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK

Peter D. Mace, Yann Wallez, Michael F. Egger et al. · Nature Communications · 2013 · 110 citations · Full text

, , +17

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine <i>In Vitro</i> and <i>In Vivo</i> to Induce Pancreatic Ductal Adenocarcinoma Regression

Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson et al. · Molecular Cancer Therapeutics · 2018 · 110 citations

, , +17

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models

Charles R. Dunlop, Yann Wallez, Timothy Isaac Johnson et al. · British Journal of Cancer · 2020 · 63 citations · Full text

, , +17

1–5 of 17